SHI Yon, XU Hui-qin. Protecting Effect of Total lridoid Glycoside in Fructus Corni Officinalis on Experimental Diabetes Models with Heart Disease[J]. Journal of Nanjing University of traditional Chinese Medicine, 2006, 22(1): 35-37.
Citation: SHI Yon, XU Hui-qin. Protecting Effect of Total lridoid Glycoside in Fructus Corni Officinalis on Experimental Diabetes Models with Heart Disease[J]. Journal of Nanjing University of traditional Chinese Medicine, 2006, 22(1): 35-37.

Protecting Effect of Total lridoid Glycoside in Fructus Corni Officinalis on Experimental Diabetes Models with Heart Disease

More Information
  • Received Date: October 07, 2005
  • Revised Date: November 08, 2005
  • OBJECTIVE To investigate into the protecting effect of total iridoid glycoside in Fructus Corni Officinalis on experimental diabetes models with heart disease. METHOD Models were made with high-fat diet and STZ injection.Two weeks later,Jiangtang Tongmai Capsule(0.8 g/kg) and ICO(0.05,0.1,0.2 g/kg) were used in the treatment for 16 weeks. RESULT In the model group,fasting blood sugar of the rats increased,the levels of serum NO and NOS decreased,plasma ET level rose markedly,heart indexes increased(P<0.05,P<0.01),overgrowth of the heart muscle occurred as revealed by optical microscope,varying degrees of matrix edema and tissue cell hyperplasia appeared,and there were mild inflammation and fibrosis in the endocardium and pericardium.After the application of ICO and Jiangtang Tongmai Capsule,the symptoms were relieved.CONCLUSION [WT5"BZ] ICO has certain protecting effect on diabetes with heart disease.
  • [1]
    许惠琴,朱荃.山茱萸环烯醚萜总苷对实验性糖尿病肾病变的保护作用[J].南京中医药大学学报,2003,19(6):342.
    [2]
    许惠琴,刘洪,郝海平,等.山茱萸环烯醚萜总苷对糖尿病大鼠胸主动脉血管内皮的保护作用[J].中国药理学通报,2003,19(6):713.
    [3]
    司晓晨.链脲佐菌素加高脂膳食诱导2型糖尿病大鼠模型[J].安徽中医临床杂志,2003,15(5):383.
    [4]
    李晨钟.胰岛家抵抗的动物模型[J].国外医学·内分泌分册,1998,18(30):144.
    [5]
    Porta M,Selba ML,Molinatti P,et al.Endothelial cell function in diabeticmicroangiopathy[J].Diabetalogia,1992,(5):161.
    [6]
    Lgarro LJ,Buga GM,Wood KS,et al.Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide[J].Proc Natl Acad Sci USA,1997,84:9265.
    [7]
    Wu G,Meininger CJ.Impaired argininal metabolism and NO synthesis in coronary endothelial cells of the spontaneously diabetic BB rat[J].Am J Pysiol,1995,269:1312.
    [8]
    Bunker CB,Goldsmith PC,Leslie TA,et al.Calcitonin gene-related peptide,endothelin-1,the cutaneous microvas-culature and Raynaud\' s phenomenon[J].Br J Dermatol,1996,134(3):399.
    [9]
    Morise T,Takeuchi Y,Kawano M,et al.Increased plasma levels of immunoreactive endothelin and Von Willebrand factor in NIDDM patients[J].Diabetes Care,1995,18(1):87.
    [10]
    Kohan DE.Endothelins in the normal and diseased kidney[J].Am J Kidney Dis,1997,29(1):2.
    [11]
    Redmond EM,Cahill PA,Hodges R,et al.Regulation of endothelin receptors by nitric oxide in cultured rat vascular smooth muscle cell[J].J Cell Physiol,1996,166(3):469.

Catalog

    Article Metrics

    Article views (1077) PDF downloads (0) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return